© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Glaukos Corporation (GKOS) stock declined over -0.57%, trading at $131.68 on NYSE, down from the previous close of $132.44. The stock opened at $132.00, fluctuating between $130.39 and $133.22 in the recent session.
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.
Employees | 907 |
Beta | 1.033 |
Sales or Revenue | $314.71M |
5Y Sales Change% | 0.255% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |
Glaukos Corporation (NYSE: GKOS) stock price is $131.68 in the last trading session. During the trading session, GKOS stock reached the peak price of $133.22 while $130.39 was the lowest point it dropped to. The percentage change in GKOS stock occurred in the recent session was -0.57% while the dollar amount for the price change in GKOS stock was -$0.76.
The NYSE listed GKOS is part of Medical - Devices industry that operates in the broader Healthcare sector. Glaukos Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Mory Gharib Ph.D.
Co-Founder
Mr. David S. Haffner
Senior Vice President of New Technologies
Ms. Michele M. Allegretto
Senior Vice President of HR
Ms. Jane E. Rady
Senior Vice President of Corporation Strategy & Bus. Devel.
Mr. Thomas William Burns
Chairman & Chief Executive Officer
Mr. Joseph E. Gilliam
Pres & Chief Operating Officer
Mr. Alex R. Thurman
Senior Vice President & Chief Financial Officer
Mr. Chris M. Calcaterra
Executive Vice President of Global Commercial Operations
Dr. Tomas Navratil Ph.D.
Chief Devel. Officer
Mr. Christopher William Lewis
Vice President of Investor Relations & Corporation Affairs
Ms. Diane W. Biagianti
Senior Vice President & Gen. Counsel
Ms. Diana A. Scherer
Vice President of Compliance & Deputy Gen. Counsel
GKOS's closing price is 122.36% higher than its 52-week low of $59.22 where as its distance from 52-week high of $136.61 is -3.61%.
Number of GKOS employees currently stands at 907.
Official Website of GKOS is: https://www.glaukos.com
GKOS could be contacted at phone 949 367 9600 and can also be accessed through its website. GKOS operates from 229 Avenida Fabricante, San Clemente, CA 92672, United States.
GKOS stock volume for the day was 254.02K shares. The average number of GKOS shares traded daily for last 3 months was 530.79K.
The market value of GKOS currently stands at $7.24B with its latest stock price at $131.68 and 54.95M of its shares outstanding.